Yan Wu Selected Research

mitaplatin

3/2012

Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Wu Research Topics

Disease

360	Neoplasms (Cancer) 05/2024 - 05/2002
108	Inflammation (Inflammations) 05/2024 - 08/2004
60	Infections 04/2024 - 10/2003
51	Neoplasm Metastasis (Metastasis) 11/2023 - 06/2004
39	Fibrosis (Cirrhosis) 05/2024 - 07/2006
37	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2005
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 02/2013
32	Breast Neoplasms (Breast Cancer) 11/2023 - 09/2002
31	Lung Neoplasms (Lung Cancer) 01/2024 - 10/2003
30	COVID-19 03/2024 - 01/2020
28	Hypoxia (Hypoxemia) 03/2024 - 10/2004
27	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2009
26	Wounds and Injuries (Trauma) 04/2024 - 01/2000
24	Stomach Neoplasms (Stomach Cancer) 05/2022 - 07/2011
21	Body Weight (Weight, Body) 12/2022 - 11/2010
20	Pain (Aches) 04/2024 - 04/2006
20	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 01/2004
20	Carcinogenesis 11/2021 - 10/2003
18	Melanoma (Melanoma, Malignant) 05/2024 - 01/2007
18	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 04/2005
17	Heart Failure 11/2023 - 03/2005
16	Hemorrhage 02/2024 - 02/2010
16	Cognitive Dysfunction 12/2023 - 11/2013
16	Necrosis 12/2023 - 11/2004
16	Carcinoma (Carcinomatosis) 12/2021 - 02/2009
15	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 12/2018
15	Myocardial Infarction 12/2023 - 01/2013
14	Pneumonia (Pneumonitis) 05/2024 - 04/2009
14	Vitiligo 04/2024 - 01/2015
14	Neuroinflammatory Diseases 01/2024 - 08/2012
14	Ischemia 09/2023 - 05/2006
14	Sepsis (Septicemia) 01/2023 - 01/2016
13	Reperfusion Injury 03/2024 - 04/2010
13	Type 2 Diabetes Mellitus (MODY) 01/2024 - 09/2007
13	Stroke (Strokes) 01/2024 - 03/2012
13	Hypertension (High Blood Pressure) 04/2022 - 07/2005
12	Disease Progression 12/2023 - 08/2002
12	Endometriosis 01/2022 - 08/2005
12	Human Influenza (Influenza) 01/2021 - 04/2006
11	Ischemic Stroke 01/2024 - 07/2008
11	Infarction (Infarctions) 12/2023 - 09/2011
11	Thrombosis (Thrombus) 08/2023 - 04/2005
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2000

Drug/Important Bio-Agent (IBA)

100	Proteins (Proteins, Gene)FDA Link 05/2024 - 09/2002
72	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2007
48	MicroRNAs (MicroRNA)IBA 01/2023 - 12/2009
46	Messenger RNA (mRNA)IBA 07/2024 - 01/2004
39	CytokinesIBA 05/2024 - 04/2006
35	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2003
27	AntibodiesIBA 12/2023 - 11/2004
26	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 09/2008
25	CollagenIBA 05/2024 - 11/2004
23	Therapeutic UsesIBA 09/2023 - 04/2007
23	LigandsIBA 03/2023 - 01/2004
23	EnzymesIBA 01/2023 - 02/2004
22	VaccinesIBA 02/2024 - 04/2006
21	LipidsIBA 10/2023 - 01/2009
19	Long Noncoding RNAIBA 12/2023 - 01/2019
18	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 11/2011
18	Phosphotransferases (Kinase)IBA 01/2024 - 07/2005
18	Interleukin-6 (Interleukin 6)IBA 12/2023 - 02/2004
18	ErbB Receptors (EGF Receptor)IBA 11/2022 - 07/2009
17	Antiviral Agents (Antivirals)IBA 09/2023 - 01/2016
15	Oxygen (Dioxygen)IBA 03/2024 - 10/2004
15	AcidsIBA 02/2024 - 01/2013
15	Peptides (Polypeptides)IBA 12/2023 - 05/2011
15	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 07/2007
14	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2010
13	AntioxidantsIBA 04/2024 - 01/2013
13	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2010
13	Epidermal Growth Factor (EGF)IBA 11/2022 - 02/2012
13	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2007
12	Small Interfering RNA (siRNA)IBA 07/2024 - 01/2012
12	Bleomycin (Blenoxane)FDA LinkGeneric 05/2024 - 06/2009
12	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2024 - 12/2013
12	Monoclonal AntibodiesIBA 01/2024 - 04/2002
12	Circular RNAIBA 12/2023 - 12/2018
12	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2011
12	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 04/2010
12	AntigensIBA 11/2022 - 04/2002
12	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 03/2012
12	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2011 - 11/2004
11	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 08/2012
11	Drug CarriersIBA 01/2023 - 01/2011
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 07/2006
11	SolutionsIBA 11/2022 - 10/2008
11	Protein Kinases (Protein Kinase)IBA 05/2022 - 09/2008
11	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2009

Therapy/Procedure

211	Therapeutics 05/2024 - 10/2003
58	Drug Therapy (Chemotherapy) 04/2024 - 07/2006
43	Immunotherapy 05/2024 - 01/2005
27	Lasers (Laser) 02/2024 - 01/2006
17	Photothermal Therapy 04/2023 - 12/2012
15	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 10/2015
14	Transplantation 01/2021 - 02/2004
12	Precision Medicine 05/2023 - 10/2016
11	Photochemotherapy (Photodynamic Therapy) 03/2024 - 12/2013
11	Ligation 12/2023 - 07/2008
11	Radiotherapy 01/2022 - 07/2006
11	Aftercare (After-Treatment) 01/2022 - 03/2005